Literature DB >> 29698919

The evolving role of lymphatics in cancer metastasis.

Rae H Farnsworth1, Marc G Achen1, Steven A Stacker2.   

Abstract

While the link between the lymphatic system and the metastatic spread of cancer is centuries old, understanding of the underlying mechanisms is still evolving. Lymphatic vessels provide a route for tumour cells to reach regional lymph nodes (LNs), which is prognostic of distant organ metastasis and poor survival. However, genomic analyses of metastatic cancer now reveal complex patterns of dissemination. The lymphatic endothelial cells lining lymphatics respond to molecular cues from the tumour microenvironment, mediating growth and remodelling of lymphatic vessels at the primary tumour, draining LNs and distant premetastatic niches. Recent studies emphasise that this not only supports metastasis but also influences antitumour immunity. Understanding the complex interactions between tumour cells, the immune system and lymphatics will be essential to inform developing therapeutic and prognostic approaches to cancer.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29698919     DOI: 10.1016/j.coi.2018.04.008

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  27 in total

1.  Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8+ T cells.

Authors:  Xiang Li; Jing Zhai; Yuke Shen; Tiancheng Zhang; Yaohui Wang; Yani He; Qiang You; Lizong Shen
Journal:  Cancer Immunol Immunother       Date:  2022-05-28       Impact factor: 6.630

Review 2.  The lymphatic vasculature: An active and dynamic player in cancer progression.

Authors:  Sara Rezzola; Elena C Sigmund; Cornelia Halin; Roberto Ronca
Journal:  Med Res Rev       Date:  2021-09-05       Impact factor: 12.388

3.  Claudin-3 inhibits tumor-induced lymphangiogenesis via regulating the PI3K signaling pathway in lymphatic endothelial cells.

Authors:  Ningjing Lei; Yanru Cheng; Jiajia Wan; Rosel Blasig; Anqi Li; Yueyue Bai; Reiner F Haseloff; Ingolf E Blasig; Linyu Zhu; Zhihai Qin
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

Review 4.  Recent advances in understanding the complexities of metastasis.

Authors:  Jessica L Chitty; Elysse C Filipe; Morghan C Lucas; David Herrmann; Thomas R Cox; Paul Timpson
Journal:  F1000Res       Date:  2018-08-01

Review 5.  Emerging Roles of Mast Cells in the Regulation of Lymphatic Immuno-Physiology.

Authors:  Sarit Pal; Shubhankar Nath; Cynthia J Meininger; Anatoliy A Gashev
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

Review 6.  Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications.

Authors:  Robert M Hughes; Jitka A I Virag
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-01

7.  Extracellular bacterial lymphatic metastasis drives Streptococcus pyogenes systemic infection.

Authors:  Matthew K Siggins; Nicola N Lynskey; Lucy E Lamb; Louise A Johnson; Kristin K Huse; Max Pearson; Suneale Banerji; Claire E Turner; Kevin Woollard; David G Jackson; Shiranee Sriskandan
Journal:  Nat Commun       Date:  2020-09-17       Impact factor: 14.919

8.  Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways.

Authors:  Benjamin Stump; Shikshya Shrestha; Anthony M Lamattina; Pierce H Louis; Woohyun Cho; Mark A Perrella; Xingbin Ai; Ivan O Rosas; Florence F Wagner; Carmen Priolo; Jonathan Astin; Souheil El-Chemaly
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

Review 9.  The Interplay Between Lymphatic Vessels and Chemokines.

Authors:  Rae H Farnsworth; Tara Karnezis; Simon J Maciburko; Scott N Mueller; Steven A Stacker
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

10.  Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.

Authors:  Zhang-Song Wu; Wa Ding; Jiajia Cai; Ghassan Bashir; Yu-Qing Li; Song Wu
Journal:  Onco Targets Ther       Date:  2019-10-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.